Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
21JUL

US renews 30-day Ebola entry ban

3 min read
09:12UTC

The US CDC issued a fresh 30-day entry ban on DRC, Uganda and South Sudan nationals on 21 June, renewing a lapsed restriction that the WHO emergency committee still opposes.

ScienceDeveloping
Key takeaway

A nationality-based entry ban renewed monthly leaves untouched the returning citizens who carry the real importation risk.

The US Centers for Disease Control and Prevention (CDC) issued a new 30-day entry ban on 21 June covering nationals of DR Congo, Uganda and South Sudan 1. The order renewed a restriction that had lapsed around 17 June without resolution. The CDC is the United States federal public-health agency; an entry ban of this kind bars foreign nationals of the named countries from boarding US-bound flights, with an expiry that forces a renewal decision roughly every month.

This is the third turn of a ratchet. The measure began as the initial 18 May ban , widened to green-card holders on 5 June , and reached its 17 June expiry unresolved before this renewal . Each cycle has expanded the population covered or reset the clock rather than tied the restriction to any epidemiological trigger, such as a fall in the Bundibugyo ebolavirus case count or a drop in cross-border movement.

The World Health Organization (WHO) emergency committee continues to advise against travel restrictions of any kind, holding that they displace rather than reduce risk and discourage honest reporting by affected states. The structural weakness in the order showed within days. The first Ebola case to reach Europe arrived in a French citizen the ban does not cover, because it screens by nationality, not by where a traveller has actually been. The next expiry falls around 21 July, when Washington must decide whether to lift, renew again, or face a challenge to a measure whose own design left the real import route open.

Deep Analysis

In plain English

Since May, the United States has been banning certain travellers from coming into the country because of the Ebola outbreak. The ban covers people from DR Congo, Uganda, and South Sudan. On 21 June, the CDC, America's public health agency, renewed that ban for another 30 days after the first version expired. The World Health Organization (WHO) has advised countries not to impose these kinds of travel bans, because the evidence from past outbreaks shows they do not stop the virus from reaching other countries and can make things worse by discouraging people from reporting symptoms. The France case three days later showed why: the person who brought Ebola to France was a French doctor, not someone from DR Congo, Uganda or South Sudan, so the US ban would not have stopped them. South Sudan does not even have any confirmed Ebola cases.

Deep Analysis
Root Causes

IHR Article 43 grants member states the right to exceed WHO recommendations, provided they notify WHO with scientific justification within 48 hours; WHO has no enforcement authority to compel compliance. The CDC's Article 43 notification filed with WHO for the 18 May order has not been publicly disclosed, nor has WHO's formal response.

The domestic political context is also structurally important: the US Department of Health and Human Services under the current administration has taken a systematically more restrictive posture on inbound travel from outbreak zones, and the CDC's public justification language mirrors the administration's wider immigration-adjacent policy framing rather than the epidemiological case.

The entry ban extends to South Sudan, which has no confirmed Bundibugyo cases: a geographic overreach that WHO noted in its DON608 risk assessment.

Escalation

The renewal signals a US posture that will hold through 21 July 2026 regardless of interim evidence.

The France importation, which occurred three days after the renewal, gives Washington a counter-argument that import risk is real, while giving WHO and EU counterparts a concrete example that nationality-based restrictions miss the actual import population.

What could happen next?
  • Risk

    Nationality-based bans may delay healthcare worker deployment from DRC, Uganda and South Sudan diaspora communities who carry clinical expertise, compounding the response capacity gap.

    Immediate · Assessed
  • Precedent

    The US ban's second renewal within a PHEIC cycle weakens the WHO Temporary Recommendation framework as a coordination instrument for future emergencies.

    Medium term · Assessed
  • Consequence

    The France importation undermines the ban's deterrence rationale but is unlikely to trigger a reversal before the 21 July expiry, given the domestic political context.

    Short term · Reported
First Reported In

Update #8 · Ebola reaches France through a screening blind spot

Al Jazeera· 25 Jun 2026
Read original
Different Perspectives
UK Government
UK Government
The Biological Security Strategy implementation report published 14 July commits the UK to deciding within twelve months whether to make DNA-synthesis screening mandatory, backed by GBP 1.83bn for biosecurity centres. It is a preemptive move on a threat that has not yet produced a UK incident.
Cambodia's Ministry of Health
Cambodia's Ministry of Health
Cambodia confirmed a nine-month-old girl in Phnom Penh as its fourth 2026 H5N1 case on 11 July, the country supplying four of the world's seven new human cases since February. The ministry's confirmed-case cadence is running well ahead of a US surveillance system that has recorded nothing new since March.
Knowledge Ecology International
Knowledge Ecology International
KEI published proposed annex text on the day IGWG7 opened that would attach benefit-sharing duties to a product's market registration, regardless of whether the manufacturer used shared samples or only downloaded sequence data. It is the Africa Group's fallback position if the sample-based bargain fails to bind.
European Union
European Union
The EU and other industrialised states backed a hybrid model built on centralised infrastructure with more flexible access terms, the opposite design choice from the Africa Group's. Brussels wants conditions handled contractually once samples reach shared facilities, not attached to national custody of the material itself.
Africa Group / Algeria
Africa Group / Algeria
Algeria, speaking for the Africa Group at IGWG7, backed distributed national and regional laboratories under binding access conditions, arguing that supplying states must keep legal control of samples rather than surrender them into shared infrastructure.
Uganda's Ministry of Health
Uganda's Ministry of Health
Uganda discharged its last confirmed patient on 16 July and opened a 42-day countdown to declaring its own outbreak over, closing at 20 cases and 2 deaths with no new case since 21 June. This is a closing chapter running alongside DR Congo's still-worsening one, contingent on a border DRC can no longer see across.